EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan

Masashi Kasai, Satoshi Nakano iD, Shota Koide iD, Shogo Otake, Meiwa Shibata iD, Kasumi Ishida-Kuroki iD, Yo Sugawara iD, Yukihiro Akeda iD, Kandai Nozu, Motoyuki Sugai iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf491 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Masashi Kasai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcal Vaccines, Streptococcus agalactiae. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMED, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of invasive neonatal and infant infections, including sepsis and meningitis. This study aimed to estimate the vaccine coverage and characterize the genomic features of pediatric invasive GBS in Japan.

Methods

We conducted a nationwide, multicenter, retrospective genomic surveillance study involving 237 GBS isolates from sterile specimens of children aged ≤15 years across 35 hospitals in Japan between 2004 and 2023. Serotyping, antimicrobial susceptibility testing, and whole-genome sequencing were performed.

Results

The estimated vaccine coverage was 98.3% for the hexavalent polysaccharide vaccine and 94.9% for the GBS-NN/NN2 protein vaccine. Erythromycin and clindamycin resistance were observed in 61.2% and 43.5%, respectively. Among the 75 CC17 isolates, 59 (78.7%) contained only PI-2B and harbored both ermB and tetO, indicating the predominance of a multidrug-resistant clone. Single nucleotide polymorphism–based analysis revealed evidence of nosocomial transmission and persistent regional circulation, particularly within the ST17 and ST23 lineages.

Conclusions

This study suggests that current maternal GBS vaccine candidates would provide broad coverage for pediatric invasive infections in Japan. The identification of persistent and regionally disseminated lineages highlights the importance of investigating potential, yet, poorly understood, transmission routes, including environmental reservoirs, to inform future prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcal InfectionsStreptococcal VaccinesStreptococcus agalactiaeAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenome, BacterialJapanMicrobial Sensitivity TestsPolymorphism, Single NucleotidePrevalenceRetrospective StudiesWhole Genome Sequencing

Stichwörter der Autor:innen

Group B StreptococcusStreptococcus agalactiaepediatrictransmissionvaccine

Substanzen

Anti-Bacterial AgentsStreptococcal Vaccines

Autor:innen und Institutionen

  • Division of Infectious Disease, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
  • Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Department of Bacteriology I, National Institute of Infectious Diseases, Toyama, Tokyo, Japan.
  • Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Center for Pediatric Infectious Diseases, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

ORCID-Profile: Satoshi Nakano, Shota Koide, Meiwa Shibata, Kasumi Ishida-Kuroki, Yo Sugawara, Yukihiro Akeda, Motoyuki Sugai

Förderung

  • AMED
  • JSPS KAKENHI

Zitieren

APA

Kasai, M., Nakano, S., Koide, S., Otake, S., Shibata, M., Ishida-Kuroki, K., Sugawara, Y., Akeda, Y., Nozu, K., & Sugai, M. (2026). Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf491

Vancouver

Kasai M, Nakano S, Koide S, Otake S, Shibata M, Ishida-Kuroki K, et al. Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf491

BibTeX
@article{Kasai2026,
  author = {Kasai, Masashi and Nakano, Satoshi and Koide, Shota and Otake, Shogo and Shibata, Meiwa and Ishida-Kuroki, Kasumi and Sugawara, Yo and Akeda, Yukihiro and Nozu, Kandai and Sugai, Motoyuki},
  title = {Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf491}
}
Kostenlos starten →